Human tissue-type plasminogen activator: from the laboratory to the bedside.
- 1 July 1985
- journal article
- abstracts
- Published by Wolters Kluwer Health in Circulation
- Vol. 72 (1) , 18-20
- https://doi.org/10.1161/01.cir.72.1.18
Abstract
No abstract availableThis publication has 10 references indexed in Scilit:
- The Thrombolysis in Myocardial Infarction (TIMI) TrialNew England Journal of Medicine, 1985
- RANDOMISED TRIAL OF INTRAVENOUS RECOMBINANT TISSUE-TYPE PLASMINOGEN ACTIVATOR VERSUS INTRAVENOUS STREPTOKINASE IN ACUTE MYOCARDIAL INFARCTIONThe Lancet, 1985
- Coronary thrombolysis and infarct size reduction after intravenous infusion of recombinant tissue-type plasminogen activator in nonhuman primates.Journal of Clinical Investigation, 1985
- Coronary Thrombolysis with Tissue-Type Plasminogen Activator in Patients with Evolving Myocardial InfarctionNew England Journal of Medicine, 1984
- Clot-Selective Coronary Thrombolysis with Tissue-Type Plasminogen ActivatorScience, 1983
- Cloning and expression of human tissue-type plasminogen activator cDNA in E. coliNature, 1983
- Purification of Human Tissue-Type Plasminogen Activator in Centigram Quantities from Human Melanoma Cell Culture Fluid and Its Conditioning for Use In VivoThrombosis and Haemostasis, 1982
- SPECIFIC LYSIS OF AN ILIOFEMORAL THROMBUS BY ADMINISTRATION OF EXTRINSIC (TISSUE-TYPE) PLASMINOGEN ACTIVATORThe Lancet, 1981
- Purification and partial characterization of plasminogen activator from human uterine tissueBiochimica et Biophysica Acta (BBA) - Protein Structure, 1979